Structure Therapeutics CMO Blas Coll Crespo disposes of USD 124,008 common shares

Bitget2026/09/22 22:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Structure Therapeutics Chief Medical Officer Blas Coll Crespo cut his ordinary share stake to 258,228 shares.
Disposed of 10,626 ordinary shares on Sept. 18 at USD 11.67 per share through tax withholding tied to RSU vesting.
Converted 12,024 ordinary shares into 4,008 American Depositary Shares on Sept. 21.
Sold 4,008 American Depositary Shares on Sept. 21 at USD 36.15 under a Rule 10b5-1 plan.
Held 1,157 American Depositary Shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Structure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002037144-26-000004), on September 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Privorotsky, Head of Trading at Goldman Sachs, is bullish on the US stock market, noting that AI intelligent agents will fundamentally eliminate friction between people, technology, and capital, resulting in structural deflationary dividends. He believes that equities are the most direct way to capture this transformation. Currently, negative factors such as seasonality, high interest rates, and geopolitical risks have been fully priced in, and the market's caution and low allocations themselves suggest further upside potential.

华尔街见闻•2026/09/23 19:16